Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Metabolism ; 28(7): 751-5, 1979 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-449710

RESUMO

The response of bone apposition to some nonphysiologic conditions was investigated. In rabbits, the normal osteogenic rhythm was totally abolished shortly following treatment of hydrocortisone at a dose of 2 mg/kg body weight daily. A new rhythm developed after the treatment was continued for 20 1/2--34 days. The rate of bone apposition was significantly depressed compared to normal data reported previously. In rats receiving one U.S.P. unit of parathyroid extract daily for 14 days, the rate of bone apposition was significantly higher than that in control rats. In both sepcies, the response to an exogenous hormone was identified for all skeletal locations. It was concluded that new bone apposition was a function of activated osteoblasts, and that this function responded only to general body control mechanisms.


Assuntos
Desenvolvimento Ósseo/efeitos dos fármacos , Osso e Ossos/fisiologia , Hidrocortisona/farmacologia , Animais , Osso e Ossos/efeitos dos fármacos , Masculino , Especificidade de Órgãos , Coelhos
2.
J Rheumatol ; 6(3): 351-9, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-314982

RESUMO

To determine the feasibility of twice daily dosing of enteric-coated aspirin (EntrophenR), a preliminary trial on 10 patients with rheumatic diseases was conducted. Three plasma salicylate levels on 2 separate occasions, 1 day apart, were determined. In 9 of the 10 patients studied at steady-state, therapeutic levels were attained (15-30 mg/dl). There were no gastrointestinal side-effects. One case developed tinnitus which resolved with a small reduction in dosage. On the basis of this short-term study, twice-daily EC-ASA appears to be effective in maintaining adequate plasma salicylate levels, and it seems to compare favourably to ASA given in multiple daily doses. On a long-term basis, it may improve patient compliance.


Assuntos
Aspirina/administração & dosagem , Doenças Reumáticas/tratamento farmacológico , Adulto , Idoso , Aspirina/farmacologia , Aspirina/uso terapêutico , Feminino , Meia-Vida , Humanos , Masculino , Pessoa de Meia-Idade , Comprimidos com Revestimento Entérico
3.
Arthritis Rheum ; 21(7): 844-8, 1978.
Artigo em Inglês | MEDLINE | ID: mdl-697954

RESUMO

A 63-year-old man developed symmetrical polyarthritis, subcutaneous nodules at the elbows, olecranon bursitis, and recurrent tenosynovitis. He was later discovered to have idiopathic hemochromatosis. Staining of the subcutaneous nodule revealed iron deposits. These manifestations which are common to rheumatoid arthritis may be seen in hemochromatotic arthropathy.


Assuntos
Artrite Reumatoide/diagnóstico , Artrite/diagnóstico , Bursite/etiologia , Hemocromatose/complicações , Tenossinovite/etiologia , Artrite/etiologia , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Nódulo Reumatoide/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...